CVE-2026-33529Disclosure(zoraxy / zoraxy)

LOWCVSS 8.8 · HIGH

Signal is active with 1 mentions in latest observed window

Immediate actions

  • Patch zoraxy zoraxy systems immediately

Recommended action window: Monitor and triage in normal cycle

NVD description

Zoraxy is a general purpose HTTP reverse proxy and forwarding tool. Prior to version 3.3.2, an authenticated path traversal vulnerability in the configuration import endpoint allows an authenticated user to write arbitrary files outside the config directory, which can lead to RCE by creating a plugin. Version 3.3.2 patches the issue.

0.5/ 10 priority

Sources & remediation

Weakness type (CWE)
CWE-22

Priority

LOW

Exploitation

NONE

PoC

YES

Patch

AVAILABLE

Momentum

NONE

Are you affected?

If you run products in this scope, you should treat this CVE as relevant to your environment.

  • zoraxy

Threat summary

  • Patch or workaround signal is available
  • 1 mentions across 1 observed day

What's happening

  • Patch or workaround mentioned in 1 signal
  • Technical details provided in 1 signal
  • Disclosure: 1 classified signal
  • 1 total mentions across 1 day

Affected systems

Vendors
Products
zoraxy

Deep dive

Activity timeline1 mentions / 1d
00111Mentions · 2026-03-26: 1Patch / Workaround · 2026-03-26: 1Technical Details · 2026-03-26: 103-26
Signal classification1 categories
Disclosure
1100.0%
Referenced assets1 URL
By indicator
Full discourse1 post
  • CVE@CVEnew
    Disclosure

    CVE-2026-33529 Zoraxy is a general purpose HTTP reverse proxy and forwarding tool. Prior to version 3.3.2, an authenticated path traversal vulnerability in the configuration import … https://www.cve.org/CVERecord?id=CVE-2026-33529

    Post summary

    The post announces CVE-2026-33529, a path‑traversal flaw in Zoraxy affecting versions before 3.3.2, and directs readers to the official CVE record for further details.

    00000143
    56.9K followersView on X
CPE platform detail1 entries

1 of 1 entries

PartVendorProductVersionTarget SWTarget HW
Appzoraxyzoraxy---

Explore more